Current Urology

Scope & Guideline

Connecting Experts, Transforming Urological Care

Introduction

Welcome to your portal for understanding Current Urology, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1661-7649
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 2008 to 2024
AbbreviationCURR UROL / Curr. Urol.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

Current Urology is dedicated to advancing the field of urology through a wide array of research focusing on clinical practices, surgical techniques, and emerging therapies. The journal emphasizes innovative methodologies and seeks to address contemporary challenges in urological health.
  1. Clinical Research in Urology:
    The journal publishes studies that investigate clinical outcomes, treatment efficacy, and patient management strategies for various urological conditions, including prostate cancer, bladder cancer, and urinary tract disorders.
  2. Surgical Techniques and Innovations:
    Research exploring minimally invasive surgical techniques, robotic surgeries, and novel surgical approaches is a significant focus, highlighting advancements that improve patient recovery and outcomes.
  3. Translational Research:
    Current Urology covers studies that bridge laboratory findings with clinical applications, particularly in the realms of cancer biology, regenerative medicine, and biomarker development.
  4. Patient-Centered Care and Quality of Life:
    A core aim is to enhance understanding of patient experiences and outcomes, emphasizing studies that assess quality of life post-treatment and the impact of urological conditions on daily living.
  5. Emerging Therapies and Technologies:
    The journal aims to disseminate knowledge on new therapeutic approaches, including immunotherapy, gene therapy, and advanced imaging techniques, to personalize treatment for urological diseases.
Current Urology is increasingly focusing on innovative and relevant themes that address contemporary challenges in urological health. The following emerging topics are gaining traction in the journal's recent publications.
  1. Precision Medicine in Urology:
    There is a growing emphasis on research that tailors treatment strategies based on individual patient characteristics, particularly in the context of prostate cancer genotyping and risk stratification.
  2. Robotic Surgery and Training:
    With advancements in robotic technology, studies examining the learning curves, surgical techniques, and outcomes associated with robotic surgeries are increasingly prevalent.
  3. Impact of COVID-19 on Urological Care:
    Research investigating how the COVID-19 pandemic has affected treatment protocols, patient preferences, and outcomes in urology is becoming more prominent, reflecting the ongoing relevance of this global health crisis.
  4. Integration of Technology in Urological Practice:
    Emerging themes related to the use of artificial intelligence, telemedicine, and virtual reality in urological diagnostics and education are gaining attention as the field adapts to technological advancements.
  5. Management of Urological Cancers:
    There is a notable increase in studies focused on the management of various urological cancers, particularly regarding novel therapies, systemic treatments, and multidisciplinary approaches to care.

Declining or Waning

While Current Urology continues to evolve, certain themes have diminished in prominence over recent years. The following areas appear to be receiving less attention in the journal's recent publications.
  1. Traditional Open Surgical Procedures:
    There has been a noticeable decline in studies focusing on traditional open surgical techniques, as the field shifts toward minimally invasive methods and robotic-assisted surgeries.
  2. Basic Science Research:
    Research that primarily focuses on basic science without direct clinical application is less frequently published, reflecting a trend towards studies with immediate relevance to clinical practice.
  3. Non-Interventional Studies:
    There is a waning interest in purely observational or non-interventional studies, as the journal emphasizes more rigorous clinical trials and comparative effectiveness research.

Similar Journals

Actas Urologicas Espanolas

Pioneering Insights for Urological Excellence
Publisher: ELSEVIER ESPANAISSN: 0210-4806Frequency: 10 issues/year

Actas Urologicas Espanolas is a prestigious journal published by Elsevier España, dedicated to the field of Urology. Established in 1977, this journal has significantly contributed to advancing knowledge and research in urological medicine and surgery, spanning a comprehensive scope that includes clinical studies, surgical techniques, and the latest innovations in the treatment of urological diseases. With an impact factor reflecting its critical role in the academic community, it is ranked Q3 in the Urology category as of 2023, placing it amongst the valuable resources for professionals and researchers. The journal is indexed under Scopus, achieving a commendable rank of #70 out of 120 in the Medicine-Urology category, situating it within the 42nd percentile. As a significant platform for sharing advancements and findings, it encourages submissions that enhance urological care and improve patient outcomes. Although not an Open Access journal, the publication remains vital for those looking to stay updated on the latest developments in urology. For more details, visit their office located at CALLE DE ZURBANO, 76-4TH FLR LEFT, MADRID, 28010, SPAIN.

Advances in Urology

Pioneering Breakthroughs in Urological Treatment
Publisher: HINDAWI LTDISSN: 1687-6369Frequency: 1 issue/year

Advances in Urology is a premier scholarly journal published by HINDAWI LTD that has been contributing to the field of urology and obstetrics since its establishment. With an impact factor reflecting its growing influence, this Open Access journal, available since 2008, ensures that researchers and professionals can readily access cutting-edge developments in urological health, surgical techniques, and innovative treatment methodologies. Based in the United States, the journal covers a wide array of topics relevant to urology and obstetrics, maintaining a notable presence in academic rankings, with a Q2 category designation in both fields as of 2023. The journal is indexed in Scopus, ranking #54 out of 120 in Urology and #95 out of 209 in Obstetrics and Gynecology, further adding to its credibility and reach. As it converges from 2009 to 2024, Advances in Urology continues to be a vital resource for researchers, professionals, and students seeking to stay abreast of significant advancements and discussions within these critical areas of medicine.

UROLOGY

Pioneering Insights in Urology Since 1973
Publisher: ELSEVIER SCIENCE INCISSN: 0090-4295Frequency: 12 issues/year

UROLOGY is a prestigious journal published by Elsevier Science Inc, renowned for disseminating high-quality research and reviews in the field of urology. With an ISSN of 0090-4295 and E-ISSN 1527-9995, this journal has been a trusted resource since its inception in 1973 and continues to provide insights into the latest advancements and clinical practices in urology, maintaining a category quartile of Q2 as of 2023. The journal ranks 50th out of 120 in the Scopus metrics for Medicine - Urology, placing it in the 58th percentile, which underscores its influence and relevance in the academic community. Although it is not structured as an open access journal, it offers a wealth of knowledge vital for researchers, healthcare professionals, and students alike, enabling them to stay abreast of evolving treatments and innovations in the field. As we move towards 2024, UROLOGY remains committed to advancing research and enhancing practices in urological care, fostering a collaborative environment among its readership.

Journal of Pediatric Urology

Fostering collaboration to enhance pediatric urological care.
Publisher: ELSEVIER SCI LTDISSN: 1477-5131Frequency: 6 issues/year

Journal of Pediatric Urology is a leading academic journal dedicated to the intersection of pediatric medicine and urological science. Published by ELSEVIER SCI LTD, this esteemed journal provides a vital platform for the dissemination of innovative research and clinical advancements in the field. With a 2023 impact factor that places it within the Q2 quartile for Pediatrics, Perinatology and Child Health, and the Q1 quartile for Urology, it is recognized among the top-tier journals in both domains. The journal covers a broad spectrum of topics from minimally invasive surgical techniques to management strategies for congenital urological disorders. This makes it an invaluable resource for researchers, clinicians, and students who seek to improve pediatric urological care. As the journal continues to evolve, it aims to foster interdisciplinary collaboration that drives further advancements in pediatric health. For those looking to avoid publication barriers, the journal retains traditional access options while contributing to the global growth of pediatric urology research from its base in the Netherlands.

Annals of Surgical Treatment and Research

Unlocking the potential of surgery through open access.
Publisher: KOREAN SURGICAL SOCIETYISSN: 2288-6575Frequency: 12 issues/year

Annals of Surgical Treatment and Research is a prominent open-access journal published by the Korean Surgical Society, dedicated to advancing the field of surgery through the dissemination of innovative research and clinical findings. With an established publication history since 2014, the journal has successfully positioned itself within the Q2 Surgery category, reflecting its significant contributions to surgical medicine as evidenced by its ranking at #247 out of 551 in Scopus. Researchers, clinicians, and academics can engage with rigorous studies, case reports, and comprehensive reviews that aim to enhance surgical practices and patient outcomes. The journal's commitment to open access promotes widespread dissemination of knowledge, making it an invaluable resource for those seeking to stay at the forefront of surgical research in a global context. For more information or to access articles, please visit the journal's website.

BMC Urology

Advancing Urological Insights for a Healthier Tomorrow
Publisher: BMCISSN: 1471-2490Frequency: 1 issue/year

BMC Urology is a premier open-access journal dedicated to advancing research in the field of urology, reproductive medicine, and miscellaneous aspects of medicine. Published by BMC since 2001 and based in the United Kingdom, this journal provides a platform for researchers, clinicians, and students to disseminate their findings and explore the latest innovations and advancements within these vital fields. With a notable impact factor and categorization in the Q2 quartile for various categories of medicine, BMC Urology stands as a reputable source, ranking 51st out of 120 in Urology and 44th out of 90 in Reproductive Medicine according to Scopus metrics. The journal fosters knowledge sharing through its open-access model, ensuring that research is accessible to all. As it converges from 2001 to 2024, BMC Urology continues to play a crucial role in shaping the landscape of urological research and providing invaluable insights into clinical practices.

Cancer Medicine

Advancing cancer care through innovative research.
Publisher: WILEYISSN: 2045-7634Frequency: 12 issues/year

Cancer Medicine is a leading open access journal published by WILEY, focusing on innovative research and advancements in the fields of Cancer Research, Oncology, and Radiology, with an impressive impact evidenced by its 2023 Q2 ranking in Cancer Research and Q1 rankings in both Oncology and Radiology, Nuclear Medicine and Imaging. With an ISSN of 2045-7634, this journal has been committed to disseminating pivotal findings since its inception in 2012, serving as a vital platform for researchers, practitioners, and students alike. The journal proudly embodies the spirit of open access, ensuring that groundbreaking cancer research is accessible to a global audience. Located in the United Kingdom, it spans a wide array of topics, promising comprehensive insights into cancer therapies, molecular mechanisms, and imaging techniques, thereby significantly contributing to the enhancement of cancer care and treatment outcomes. Researchers interested in exploring the latest advancements in cancer medicine will find this journal an indispensable resource.

Bladder Cancer

Unveiling breakthroughs in bladder cancer management.
Publisher: IOS PRESSISSN: 2352-3727Frequency: 4 issues/year

Bladder Cancer, published by IOS PRESS, is a premier open access journal dedicated to advancing the field of oncology and urology, with a specific focus on bladder cancer research and treatment. Established in 2015 and continuing through to 2024, this journal aims to disseminate high-quality, peer-reviewed research that contributes to the understanding, diagnosis, and management of bladder cancer, a critical area of concern in urological oncology. With a robust publication record now encompassing open access since 2023, Bladder Cancer ensures accessibility to vital research for clinicians, researchers, and scholars worldwide. The journal's rankings in Scopus reflect its commitment to excellence, holding a Q3 category in both oncology and urology, with Scopus ranks of #78 in Urology and #285 in Oncology, showcasing its growing influence in the scientific community. By fostering dialogue and innovation, Bladder Cancer serves as an essential resource for those committed to improving patient outcomes in bladder oncology.

Translational Lung Cancer Research

Empowering global collaboration in lung cancer research.
Publisher: AME PUBLISHING COMPANYISSN: 2218-6751Frequency: 6 issues/year

Translational Lung Cancer Research is a leading journal dedicated to advancing the field of oncology, particularly focusing on groundbreaking discoveries in lung cancer treatment and management. Published by AME Publishing Company, this journal boasts an impressive Q1 classification in the 2023 Oncology category, reflecting its significant contribution to the scientific community, with an outstanding Scopus rank of #92 out of 404 in Medicine _ Oncology, placing it in the 77th percentile. With its commitment to open access, the journal fosters international collaboration and accessibility, making cutting-edge research available to a wide audience. The scope of Translational Lung Cancer Research encompasses clinical trials, experimental studies, and translational research that bridge the gap between laboratory findings and clinical applications. Researchers, professionals, and students seeking to keep abreast of the latest developments in lung cancer research will find invaluable insights within its pages. For further information, please contact at FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG.

Indian Journal of Urology

Empowering Urologists with Open Access Insights.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0970-1591Frequency: 4 issues/year

Indian Journal of Urology, published by Wolters Kluwer Medknow Publications, is a premier open-access journal dedicated to the field of urology, serving as a vital platform for researchers and clinicians to disseminate groundbreaking findings since its inception in 2001. With an ISSN of 0970-1591 and an E-ISSN of 1998-3824, this journal has established itself as a crucial resource for advancing knowledge in urological practices, particularly within the Indian context. Recognized in the 2023 Scopus Rankings with a classification of Q3 in Urology, it stands at a significant position (Rank #71 out of 120) with a 41st percentile performance, highlighting its role in contributing to the global discourse in urological medicine. The journal provides open access options, ensuring that high-quality research is readily available to a broad audience, fostering collaboration and innovation. Publishing significant studies from various converged years, including from 1984 to 1999 and more recently from 2006 to 2024, Indian Journal of Urology is essential for professionals seeking to stay updated with the latest advances and best practices in urology.